Wealthspire Advisors (Maryland)’s VanEck Biotech ETF BBH Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$1.17M	Buy	+7,227	New	+$1.18M	0.04%	174

Other funds holding BBH

PAG

Pinnacle Advisory Group Columbia, Maryland $2.17B AUM 39.21% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s BBH Position: Q3 2020 in Review

Wealthspire Advisors (Maryland) opened a new position in VanEck Biotech ETF (BBH) in Q3 2020: 7,227 shares worth $1.17M. The stake represents 0.04% of the portfolio and ranks #174 among its holdings.

101 funds tracked by Wall St. Rank hold BBH as of Q3 2020.

Wealthspire Advisors (Maryland) held 7,227 shares of VanEck Biotech ETF worth $1.17M as of Q3 2020.
VanEck Biotech ETF was a new Wealthspire Advisors (Maryland) position in Q3 2020.
VanEck Biotech ETF made up 0.04% of Wealthspire Advisors (Maryland)'s portfolio in Q3 2020, its #174 holding.
101 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2020.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q3 2020, filed 13 Nov 2020.